Results 191 to 200 of about 3,458,846 (288)

Parental Knowledge and Acceptance of HPV Vaccine in Rabigh's School, Saudi Arabia. [PDF]

Ann Glob Health
Alghanmi R, Alkhalawi E, Albeladi R, Albeladi S, Alghamdi M, Fayoumi A, Nassif R.   +6 more
europepmc   +1 more source

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks, Anna Wolska, Diala Ghazal, Dejan Jakimovski, Bianca Weinstock‐Guttman, Alexander Burnham, Niels Bergsland, Michael G. Dwyer, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +10 more
wiley   +1 more source

Health beliefs model and vaccine acceptance: insights from the COVID-19 pandemic among non-medical personnel in Mwanza, Tanzania. [PDF]

BMC Public Health
Mosha GW, Leeyio TR, Kitambo R, Konje ET.   +3 more
europepmc   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Transforming data to delight: AI-led campaign personalization shapes digital natives' intention to accept over a TAM-VAM approach. [PDF]

Front Artif Intell
Durgha Devi L, Arumugam T.
europepmc   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Knowledge and Attitude Toward Human Papillomavirus (HPV) and Its Vaccination in the Saudi Population: A Systematic Review. [PDF]

Cureus
Alshehri E, Akkour KM, Abdel Wahab AS, Al-Shaikh GK, Alayed N, Neyazi S, Almalki A, Smisim M, Abdelrazeq M, Gamal M.   +9 more
europepmc   +1 more source

CHALLENGE ACCEPTED

AJN, American Journal of Nursing, 1966
openaire   +2 more sources

Deep Learning–Assisted Differentiation of Four Peripheral Neuropathies Using Corneal Confocal Microscopy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Peripheral neuropathies contribute to patient disability but may be diagnosed late or missed altogether due to late referral, limitation of current diagnostic methods and lack of specialized testing facilities. To address this clinical gap, we developed NeuropathAI, an interpretable deep learning–based multiclass classification ...
Chaima Ben Rabah, Ioannis N. Petropoulos, Mark Stettner, Maryam Ferdousi, Uazman Alam, Nathan Efron, Ahmed Serag, Rayaz A. Malik   +7 more
wiley   +1 more source

An Integrated Analysis of Factors Influencing Acceptance of Care Robots Among Older Korean Adults. [PDF]

Healthcare (Basel)
Yoon HJ, Ban SW, Han YM, Shin HR, Kim YS, Shin WC, Yoo SD, Park JH.   +7 more
europepmc   +1 more source